Sarvesh Rajan

Endocrinology in Du Bois, Pennsylvania

Practice Details

Address
145 Hospital Ave
Du Bois, PA 15801
Geocoded location: 41.1148, -78.7766
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
MD
NPPES Enumeration
Listed with NPPES since 2006
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
June 2011

Specialty taxonomies on file (2)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 3 Endocrinology, Diabetes & Metabolism practices in Du Bois carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Sarvesh Rajan's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 814-375-4089.

GLP-1 access in Du Bois, Pennsylvania

Adult obesity rate
33.4%
#20 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$209/mo
Typical Pennsylvania telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Pennsylvania Medicaid, obesity indication

About 33.4% of Pennsylvania adults have obesity (BMI 30+), ranking the state #20 of 50 (CDC BRFSS). Our directory currently lists 9 GLP-1-relevant clinics in Du Bois. If a cash-pay route makes more sense, compounded semaglutide through Pennsylvania telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.

Explore more Pennsylvania options on the best Pennsylvania GLP-1 providers page, browse every Du Bois listing in the Du Bois clinic directory, or read the Pennsylvania Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Du Bois

Other Du Bois listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Pennsylvania addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Pennsylvania telehealth partners:

Featured Partners · Du Bois

Featured GLP-1 providers serving Du Bois

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Du Bois options on the Du Bois clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Du Bois obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Sarvesh Rajan's specialty taxonomy but not the specific medications it prescribes or its current service menu. Sarvesh Rajan is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 814-375-4089 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Sarvesh Rajan's primary specialty on file is Endocrinology.
Sarvesh Rajan is located at 145 Hospital Ave, Du Bois, PA 15801. The phone number listed in the registry is 814-375-4089. Its full record is public in the CMS National Provider registry under NPI 1912915554.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Sarvesh Rajan is currently accepting new patients. Call the practice at 814-375-4089 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.